Reference // Research
Research dossiers
What each compound is, the mechanism described in the in-vitro literature, the methodological limits that come with it, and how its lot is verified. No dosage, no protocol and no therapeutic claim.
Buying guide
- Research peptide prices: how to compare per milligram Retatrutide, BPC-157, GHK-Cu, TB-500, NAD+: why the price of a vial cannot be compared, and how to work out what a research peptide really costs. 7 min
- How to choose a peptide supplier in France: 8 checkable criteria Analysis report, seller identity, delivery, price per milligram: what a laboratory can check before buying research peptides online. 9 min
Comparison
- GLOW vs KLOW: the difference is one tripeptide Three components or four: what separates the two blends, what that costs analytically, and when a blend is the wrong material. 6 min
- KLOW peptide: what is actually in the blend Four compounds under one name — KPV, GHK-Cu, BPC-157 and TB-500 — and what a four-component mixture can and cannot establish. 7 min
- The "Wolverine stack": what BPC-157 + TB-500 actually is A nickname from forums, not from the literature — and two peptides with nothing structural in common. 7 min
- BPC-157 or TB-500: comparing two peptides studied in tissue repair Two peptides often cited together, but with two origins, two sizes and two different studied mechanisms. 8 min
- Copper peptides and cosmetic peptides: GHK-Cu, AHK-Cu and Snap-8 compared Two copper peptides that carry a copper ion, and an octapeptide that carries none: what brings them together, and what separates them. 8 min
- CJC-1295, Ipamorelin, GHRP-6: GHRH analogues and GHRPs compared Two families of growth hormone secretagogues, two different receptors — and the difference between CJC-1295 with and without DAC. 8 min
- Melanotan II (Melanotan 2) or PT-141: comparing two melanocortins Two cyclic α-MSH analogues that differ only at their C-terminal end — and whose regulatory statuses have nothing in common. 7 min
- Semaglutide, tirzepatide, retatrutide, mazdutide: the GLP-1 agonists compared One, two or three receptors: what separates the latest generation of GLP-1 agonists, and what their trials do — and do not — allow anyone to compare. 9 min
- Semax or Selank: comparing two research heptapeptides The same Pro-Gly-Pro tail, two different heads: an ACTH fragment on one side, tuftsin on the other. 7 min
Laboratory guide
- Bacteriostatic water: composition, pharmacy or laboratory, storage What bacteriostatic water is, what separates it from the water for injections sold in pharmacies, and how to store it in the laboratory. 6 min
- Endotoxins and sterility: what a LAL test measures, and what an HPLC report does not Purity, identity, content, endotoxins, sterility: five different measurements, often confused. What each one establishes, and which document carries it. 7 min
- EC50, half-life, bioavailability, proteolysis: a peptide's parameters explained The four concepts found throughout the peptide literature, defined simply: potency, duration, available fraction and enzymatic degradation. 7 min
- Peptide, polypeptide, protein: definitions and differences Peptide bond, oligopeptide, polypeptide, protein: what these words mean and where the boundaries fall, with real examples from two to fifty-one amino acids. 6 min
- Oral peptides: why bioavailability is the real challenge Acidity, enzymes, the intestinal barrier: what stops a swallowed peptide, the strategies that get a fraction through, and what that means for capsule and tablet forms. 8 min
- Solid-phase peptide synthesis (SPPS): how a research peptide is made From Merrifield's method to Fmoc chemistry: the synthesis cycle, where impurities come from, and why a long peptide costs more than a short one. 9 min
- Storing lyophilised peptides: temperature, humidity, light From the arrival of the parcel to the freezer: what degrades a lyophilisate, and the habits that preserve its stability before reconstitution. 7 min
- How to read a peptide lot analysis report (COA) What an HPLC and mass spectrometry report actually demonstrates — and the three things it does not. 11 min
- Reconstituting a research peptide: calculation, solvent and storage The complete method for going from a lyophilised vial to a solution of known concentration, in the laboratory. 10 min
Literature review
- Retatrutide dosing: the doses used in the published trials What the phase 2 protocols actually specified — four dose levels, a gradual escalation, and why the escalation is not a detail. 7 min
- Retatrutide and weight loss: what the clinical literature reports A review of the published phase 2 results — figures, doses studied and adverse events reported. 10 min
Regulatory framework
- RUO (Research Use Only): what the label means on a peptide “For research use only”: where the wording comes from, what it commits to, and what it does not guarantee. 6 min
- Peptides and doping: what the WADA 2026 Prohibited List says BPC-157, TB-500, CJC-1295, GHRPs, MOTS-c: section by section, the peptides covered by the list in force since 1 January 2026, and the French framework that applies it. 9 min
- Peptides in pharmacies, without a prescription, legal? What French law says Why BPC-157 and retatrutide are not found in pharmacies, why “without a prescription” does not apply, and what separates a medicine from a reference material. 8 min
Research dossier
- CJC-1295 with DAC — dossier on the long-acting GHRH analogue The same GRF (1-29) fragment as CJC-1295 without DAC, plus a reactive group that hooks it to albumin — and changes its half-life by an order of magnitude. 7 min
- GHRP-2 (pralmorelin) — dossier on the second-generation GHRP secretagogue The only GHRP to have obtained a marketing authorisation — in Japan, as a diagnostic agent. 7 min
- Gonadorelin — dossier on synthetic GnRH A decapeptide identical to the natural hypothalamic hormone, whose effect depends entirely on the rhythm of exposure. 7 min
- Hexarelin — dossier on the GHS-R1a receptor secretagogue A hexapeptide derived from GHRP-6, among the most potent of its family — and one of the few to also bind the CD36 receptor. 7 min
- LL-37 — dossier on human cathelicidin, an antimicrobial peptide The only human cathelicidin: a cationic 37-amino-acid helix, both antimicrobial and immunomodulatory. 8 min
- Mazdutide — dossier on the GLP-1 / glucagon dual agonist An oxyntomodulin analogue engaging two receptors, GLP-1R and GCGR — the first of its class to be authorised, in China, in 2025. 8 min
- Sermorelin — dossier on the GHRH (1-29) fragment The first 29 amino acids of human GHRH: the shortest fully active fragment, and the starting point of the whole analogue family. 7 min
- Tesamorelin — dossier on the stabilised GHRH analogue The complete 44-amino-acid GHRH, protected from degradation by a single group added at its end. 7 min
- Thymalin — dossier on the thymic polypeptide complex Not a molecule but a set of peptides extracted from the thymus — and a literature almost entirely from the Russian bioregulation school. 7 min
- GLP-1: the hormone, the receptor and the generations of agonists What GLP-1 actually is, why it is degraded within two minutes, and how the agonists work around that. 11 min
- SS-31 — cardiolipin and the inner mitochondrial membrane dossier A tetrapeptide that targets a lipid rather than a receptor — a rare mechanism in peptide pharmacology. 7 min
- SLU-PP-332 — pan-ERR agonism dossier A small-molecule ERR agonist — not a peptide, and analytically different. 6 min
- Semax — ACTH fragment and BDNF expression dossier A heptapeptide derived from an ACTH fragment stripped of hormonal activity. 6 min
- Selank — tuftsin analogue dossier A stabilised analogue of an endogenous immune tetrapeptide. 6 min
- PT-141 — melanocortin MC4R selectivity dossier A metabolite of Melanotan II, where the loss of one group changes the selectivity. 6 min
- Pinealon — neuronal regulatory tripeptide dossier A tripeptide from the same research school as epitalon, studied on neuronal models. 6 min
- Oxytocin — OXTR receptor and vasopressin selectivity dossier A cyclic nonapeptide, among the first peptides ever synthesised chemically. 6 min
- Methylene blue — mitochondrial redox cycling dossier A historic dye whose redox reactivity makes it a mitochondrial research tool. 6 min
- Melanotan II — non-selective α-MSH analogue dossier A cyclic α-MSH analogue, non-selective between melanocortin receptor subtypes. 6 min
- KPV — C-terminal α-MSH motif dossier The minimal C-terminal motif of α-MSH, studied independently of the melanocortin receptors. 6 min
- Kisspeptin-10 — KISS1R receptor dossier The minimal active fragment of a peptide central to the regulation of the reproductive axis. 6 min
- Ipamorelin — GHSR receptor selectivity dossier A pentapeptide noted in the literature for its receptor selectivity. 6 min
- IGF-1 LR3 — reduced IGFBP affinity dossier An analogue engineered to escape its binding proteins — a deliberate structural modification. 7 min
- Glutathione — GSH/GSSG redox couple dossier The principal intracellular thiol antioxidant, and a measurable redox buffer. 6 min
- GHRP-6 — first-generation secretagogue dossier A first-generation hexapeptide, the historical reference of the secretagogue family. 6 min
- Epitalon — tetrapeptide and telomerase expression dossier A short tetrapeptide studied for its reported influence on telomerase expression. 7 min
- DSIP — dossier on a nonapeptide with no identified receptor A nonapeptide isolated for an observed effect before its receptor was identified. 6 min
- CJC-1295 without DAC — GHRH analogue dossier A GHRH analogue stabilised by four substitutions targeting its cleavage points. 7 min
- Cagrilintide — amylin analogue dossier An amylin analogue designed for an extended half-life, studied alongside the incretin agonists. 7 min
- ARA-290 — innate repair receptor dossier An erythropoietin fragment designed to separate tissue repair from erythropoiesis. 6 min
- AOD-9604 — hGH(176-191) fragment dossier A growth hormone fragment stripped of its receptor-binding domain. 6 min
- AHK-Cu — copper tripeptide follicular dossier The copper analogue of GHK, studied specifically on follicular models. 6 min
- Adamax — combined-formulation dossier and the limits of attribution A combined formulation: each component has to be characterised separately. 6 min
- 5-Amino-1MQ — NNMT inhibition dossier An enzyme inhibitor — a target and a methodology distinct from those of the peptides. 5 min
- NAD+ — redox cofactor and sirtuin substrate dossier A central redox cofactor, and also a substrate consumed by the signalling enzymes. 10 min
- MOTS-c — mitochondrial-derived peptide dossier One of the few peptides encoded by the mitochondrial genome rather than by nuclear DNA. 7 min
- GHK-Cu, the copper peptide — copper complex and extracellular matrix dossier The copper peptide: a tripeptide forming a copper(II) complex of defined geometry, studied in matrix remodelling. 8 min
- TB-500 — actin sequestration dossier An actin-sequestering peptide, studied for cytoskeletal reorganisation in culture. 6 min
- BPC-157 — cell migration and the FAK pathway dossier A sequence derived from a gastric juice protein, widely studied in cell migration models. 8 min
- Retatrutide — GIP, GLP-1 and glucagon triple agonist dossier An agonist at all three receptors — GIP, GLP-1 and glucagon — in clinical development. 12 min
Topic guide
- Peptides and muscle growth: what the literature has actually measured Which compounds the hypertrophy literature studies, what endpoint each one actually reports, and where the evidence stops. 8 min
- Peptides and fat loss: what each compound's literature actually reports Incretin agonists, a growth hormone fragment, and metabolic activators — three separate bodies of evidence of very unequal strength. 8 min
- Peptides and sleep: DSIP, orexin, GHRH — what the research has established Sleep is regulated in part by peptides. One of them, orexin, changed the understanding of narcolepsy; another, DSIP, is still waiting for its receptor. 8 min